Hacker News Reader

> They worked with 11 patients, all of who had obesity and type 2 diabetes and take an oral drug that helps control glucose levels, called metformin.

This is such a tiny and specific sample compared to the unqualified claim they make in the title. Unfortunately, this level of rigor seems to be par for the course in the world of nutrition.

View on HN

Nondiabetic Subjects: https://pubmed.ncbi.nlm.nih.gov/30381620/

The sample size is perfectly acceptable for a single study. The article also indicates further research will be done.

The claim perfectly summarizes the findings of their research, contained to this study.

That fact that the conclusion is limited to the study is implied. It's expected to be naturally understood by all.

Imagine headlines if they had to explain every single bit of nuance. That's what the article itself is for.

Reply on news.ycombinator.com